Efficacy and safety of the WT-2009 chemotherapy protocol in treatment of Wilms' tumor in children.
- Author:
Xia GUO
1
;
Chao LIN
;
Ju GAO
;
Chen-Yan ZHOU
;
Qiang LI
;
Yi-Ping ZHU
Author Information
- Publication Type:Journal Article
- MeSH: Antineoplastic Agents; adverse effects; therapeutic use; Child; Child, Preschool; Female; Humans; Infant; Kidney Neoplasms; drug therapy; mortality; pathology; Male; Survival Rate; Wilms Tumor; drug therapy; mortality; pathology
- From: Chinese Journal of Contemporary Pediatrics 2015;17(3):262-265
- CountryChina
- Language:Chinese
-
Abstract:
OBJECTIVETo evaluate the efficacy and safety of the WT-2009 chemotherapy protocol for Wilms' tumor (WT) in children.
METHODSThe clinical data of 34 children with newly-diagnosed WT between July 2009 and December 2013 were retrospectively analyzed. Among the 34 children, 2 died before treatment, 6 children did not accept therapy and 26 accepted the chemotherapy based on the WT-2009 chemotherapy protocol. Kaplan-Meier method was used to estimate the 2-year survival rate.
RESULTSThe pathological analysis revealed the favorable histology WT was common (88%, 30/34). The most common first manifestation was abdominal masses (56%, 19/34). Among the 26 patients who accepted the chemotherapy based on the WT-2009 protocol, complete remission was achieved in 24 cases (92%), partial remission was achieved in 1 case (4%), and disease relapse was found in 1 case (4%). Severe pulmonary infection occurred in 1 case in the course of treatment. The 2-year overall survival rate and event-free survival rate were 100% and 89.7% respectively.
CONCLUSIONSFavorable histology is most common pathological type in children with WT. The chemotherapy based on the WT-2009 protocol for WT can produce a favorable prognosis and a high tolerance.
